Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,566 | 1,550 | 3,440 | 10,091 | 4,098 |
| Cost of Goods | 557 | 2,349 | 1,994 | 4,153 | 1,562 |
| Gross Profit | 1,009 | -799 | 1,446 | 5,938 | 2,536 |
| Operating Expenses | 7,043 | 11,041 | 10,961 | 24,838 | 12,477 |
| Operating Income | -5,477 | -11,491 | -8,521 | -18,747 | -9,379 |
| Interest Expense | 219 | 214 | 217 | 514 | 1,245 |
| Other Income | -485 | 145 | 103 | 327 | 733 |
| Pre-tax Income | -6,181 | -11,560 | -8,635 | -18,934 | -9,891 |
| Income Tax | 1 | 1 | 2 | 3 | 14 |
| Net Income Continuous | -6,182 | -11,561 | -8,637 | -18,937 | -9,905 |
| Net Income Discontinuous | -460 | -1,024 | N/A | N/A | -726 |
| Net Income | $-6,642 | $-12,585 | $-8,637 | $-17,687 | $-10,631 |
| EPS Basic Total Ops | -4.09 | -7.62 | -5.52 | -10.92 | -6.73 |
| EPS Basic Continuous Ops | -3.83 | -7.03 | -5.17 | -10.93 | -6.29 |
| EPS Basic Discontinuous Ops | -0.26 | -0.59 | N/A | N/A | -0.44 |
| EPS Diluted Total Ops | -4.09 | -7.62 | -5.52 | -10.92 | -6.73 |
| EPS Diluted Continuous Ops | -3.83 | -7.03 | -5.17 | -10.93 | -6.29 |
| EPS Diluted Discontinuous Ops | -0.26 | -0.59 | N/A | N/A | -0.44 |
| EPS Diluted Before Non-Recurring Items | -3.83 | -7.03 | -5.52 | -4.14 | -6.65 |
| EBITDA(a) | $-4,653 | $-10,634 | $-7,292 | $-5,656 | $-7,984 |